# Harbor Health Care UCITS ETF (WELP) **Page:** https://fundology.uk/fund/welp · ISIN IE00BJQTJ848 ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 13/11/2026, WELP (Harbor Health Care UCITS ETF, ISIN IE00BJQTJ848) closed at £6.54 on the London Stock Exchange. Its ongoing charge is 0.59% a year (about £59 on £10,000). Over the five years to 13/11/2026 its total return was −21.1%, or −38.4% after UK CPIH inflation. ## Summary Harbor Health Care UCITS ETF Accum Shs -A- USD is an exchange-traded fund (ETF) from HANetf, launched in 2019. It tracks the Indxx Advanced Life Sciences & Smart Healthcare Thematic Index. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.59% a year — about £59 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. Latest close: **£6.54** (13/11/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | WELP | | ISIN | IE00BJQTJ848 | | Also listed as | WELL (London Stock Exchange, US dollars), W311 (Xetra, euros) | | Category | Healthcare | | Type | ETF | | Provider | HANetf | | Tracks | Indxx Advanced Life Sciences & Smart Healthcare Thematic Index | | Income | Accumulating | | Ongoing charge | 0.59% a year (£59 per £10,000) | | Fund size | £9.8m | | Launched | 2019 | | Domicile | Ireland | | UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 01/04/2019 | ## Past returns (periods to 13/11/2026) After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation. | Window | Return | After CPIH inflation | Measured as | |---|---|---|---| | 1 year | +8.26% | +4.42% | income reinvested | | 3 years | +28.93% | +16.48% | income reinvested | | 5 years | -21.06% | -38.38% | income reinvested | Returns: as reported (delayed data). Inflation: UK CPIH, latest month published. ## Calendar-year returns Calendar-year returns of Harbor Health Care UCITS ETF Accum Shs -A- USD in pounds (price, with income reinvested in the fund): 2022 −22.3%, 2023 −2.4%, 2024 −6.3%, 2025 +8.1%; 2026 to 13/11/2026 +11.0%. Returns of Harbor Health Care UCITS ETF Accum Shs -A- USD in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +9.7%; to 30/09/2025: +2.1%; to 30/09/2024: +2.7%; to 30/09/2023: −13.3%; to 30/09/2022: −23.2%. | Year | Return | After CPIH inflation | Measured as | |---|---|---|---| | 2022 | -22.3% | -28.9% | Price | | 2023 | -2.4% | -6.3% | Price | | 2024 | -6.3% | -9.5% | Price | | 2025 | +8.1% | +4.4% | Price | | 2026 to 13/11/2026 | +11.0% | +7.4% | Price | ## Risk metrics | Window | Volatility | Max drawdown | |---|---|---| | 1 year | 20.90% | -16.77% | | 3 years | 19.54% | -19.21% | | 5 years | 21.27% | -43.38% | ## Largest fall Volatility of Harbor Health Care UCITS ETF Accum Shs -A- USD in pounds, annualised from weekly returns to 13/11/2026: 20.9% over 1 year, 19.5% over 3 years, 21.3% over 5 years. Largest fall in the price of Harbor Health Care UCITS ETF Accum Shs -A- USD since November 2021, in pounds: −41.6% from 19/11/2021 to 11/04/2025. The lowest 12-month return of Harbor Health Care UCITS ETF Accum Shs -A- USD in pounds (price, with income reinvested in the fund) since January 2021 was −36.0% (12 months to 17/06/2022); the highest was +27.2% (12 months to 03/07/2026). On 13/11/2026 the price of Harbor Health Care UCITS ETF Accum Shs -A- USD was 18.9% below its highest weekly close since November 2021 (19/11/2021), in pounds. ## Charges compared with similar funds Ongoing charge of Harbor Health Care UCITS ETF Accum Shs -A- USD 0.59% a year. Compared on 14/11/2026, 3 of the 28 other healthcare funds charge more, 0 the same and 25 less (share classes counted once). ## Charges & eligibility - Ongoing charges figure (OCF): **0.59%** per year - Stocks and shares ISA eligible: usually (check with your platform) - SIPP eligible: usually (check with your provider) - ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify. ## Questions people ask **What is the ongoing charge of WELP?** The ongoing charge of WELP is 0.59% a year — about £59 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Harbor Health Care UCITS ETF Accum Shs -A- USD 0.59% a year. Compared on 14/11/2026, 3 of the 28 other healthcare funds charge more, 0 the same and 25 less (share classes counted once). **What does WELP track?** WELP tracks the Indxx Advanced Life Sciences & Smart Healthcare Thematic Index. **Is WELP accumulating or distributing?** WELP is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. **What is the ISIN of WELP?** The ISIN of WELP is IE00BJQTJ848. An ISIN identifies one exact share class of a fund; WELP is its ticker on the London Stock Exchange. The same share class is also listed as WELL (London Stock Exchange, US dollars) and W311 (Xetra, euros). **What were WELP’s returns in each of the last five years?** Calendar-year returns of WELP in pounds (price, with income reinvested in the fund): 2022 −22.3%, 2023 −2.4%, 2024 −6.3%, 2025 +8.1%; 2026 to 13/11/2026 +11.0%. Past performance is not a guide to future returns. **How has WELP done after inflation?** Over the five years to 13/11/2026 WELP’s total return was −21.1%, or −38.4% after UK CPIH inflation. Past performance is not a guide to future returns. --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.